Hhr Asset Management, LLC Regenxbio Inc. Transaction History

Hhr Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $777,399 - $1.16 Million	-23,130 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $212,160 - $394,800	-8,000 Reduced 25.7%	23,130 $1.05 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $47,807 - $71,260	-1,770 Reduced 5.38%	31,130 $857,000
Q2 2020 Aug 07, 2020	SELL	$27.75 - $43.44 $151,237 - $236,748	-5,450 Reduced 14.21%	32,900 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $132,288 - $171,852	-3,830 Reduced 9.08%	38,350 $1.57 Million

Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $1.77 Million - $2.5 Million	42,180 New	42,180 $2.17 Million

193

42M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $458M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhr Asset Management, LLC with notifications on news.